News Conference News AHA 2025 Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight Caitlin E. Cox November 18, 2025
News Conference News AHA 2025 Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF Todd Neale November 17, 2025
News Conference News AHA 2025 DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation Todd Neale November 12, 2025
News Conference News AHA 2025 LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF Caitlin E. Cox November 09, 2025
News Conference News AHA 2025 DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients Michael O'Riordan November 09, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Conference News AHA 2024 Two Trials Provide Insights Into Catheter Ablation Options for Persistent AF Todd Neale November 21, 2024
News Conference News AHA 2024 Extreme Heat Seems to Spark More Atrial Arrhythmias in IED Patients Todd Neale November 19, 2024
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
Presentation AHA 2024 Comparison of Linear Ablation Plus Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone for Persistent Atrial Fibrillation Presenter: Chenyang Jiang November 18, 2024
Presentation AHA 2024 Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation Presenter: Oussama M. Wazni November 16, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News AHA 2023 Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate Todd Neale November 16, 2023
Presentation AHA 2023 The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation Presenter: Jeff Healey November 16, 2023
Presentation AHA 2023 Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial Presenter: Nina Becher November 14, 2023
News Conference News AHA 2023 Simultaneous Dual Cardioversion of AF Lessens Failure Rates in Obese Patients Todd Neale November 14, 2023
News Conference News AHA 2023 Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications Todd Neale November 13, 2023